APR 19, 2018 1:19 PM PDT

New Treatment for Psoriasis and Other Autoimmune Diseases

WRITTEN BY: Kara Marker

The same compound that helps immune cells detect bacteria during an invasion could help scientists design a new drug to treat psoriasis, an autoimmune disease. From the Washington University School of Medicine, researchers use a modified form of a compound called itaconate in mice models of psoriasis.

Characteristic patches of plaque psoriasis. Credit: Eisfelder

"We are taking advantage of the body's own anti-inflammatory power and showing that it can help in real situations when your own immune system is hurting you," explained senior author Maxim Artyomov, PhD.

Psoriasis is an autoimmune disease characterized by accelerated growth of skin cells that the body can’t shed. Instead, the cells build up on the skin, causing the characteristic patches, often on the knees, elbows, lower back, or scalp.

Inflammation is a double-edged sword. Inflammation (redness, swelling) is necessary for recruiting immune cells to the scene of an infection or injury to ward off pathogens and heal wounds, but the hero turns villanous when the inflammation is excessive or unwarranted.

Itaconate suppresses inflammation, which is the foundational issue behind autoimmune diseases like psoriasis, rheumatoid arthritis, lupus, and others. While the present study looked at the potential of itaconate to treat psoriasis, the compound may also be capable of treating other diseases too.

The main focus of the present study was identifying how and why itaconate suppresses inflammation. Researchers started by treating isolated inflammatory cells from mice and humans with a modified form of itaconate, dimethyl itaconate. They saw that the compound reduces levels of a key protein in the IL-17 inflammatory pathway, lkappaBzeta.

This inflammatory pathway is significant in the fight against bacteria and other pathogens, but it’s also partially responsible for causing autoimmune diseases. Genetic studies linked variations in the gene that codes for lkappaBzeta to an increased risk for developing psoriasis. Would reducing levels of lkappaBzeta treat psoriasis?

In the mice, researchers induced psoriasis-like symptoms while giving them doses of either placebo or dimethyl itaconate once a day for one week. Dimethyl itaconate successfully thwarted psoriasis as opposed to the placebo. Follow-up studies already in progress include testing itaconate compounds and multiple sclerosis in mice.

“Everyone thought that if it is produced by inflammatory cells it should fight infection, but no - it's anti-inflammatory,” Artyomov said. “Now we know that itaconate compounds can help with autoimmune diseases, specifically in psoriasis and potentially in multiple sclerosis. This small molecule is turning out to be really powerful."

The present study was published in the journal Nature.

Sources: American Academy of Dermatology, Washington University School of Medicine

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
OCT 02, 2020
Immunology
Stop the Clot: A New Antibody Treatment for Thrombosis
OCT 02, 2020
Stop the Clot: A New Antibody Treatment for Thrombosis
Blood clotting helps stem the bleeding from a wound, suppressing blood loss and stopping pathogenic microorganisms from ...
OCT 06, 2020
Drug Discovery & Development
New Immunotherapy Drug Effective Against Lung Cancer
OCT 06, 2020
New Immunotherapy Drug Effective Against Lung Cancer
A new study has confirmed that Tecentriq, an immunotherapy drug, improves survival rates among those with newly diagnose ...
OCT 11, 2020
Microbiology
Getting Closer to a Vaccine for Flaviviruses
OCT 11, 2020
Getting Closer to a Vaccine for Flaviviruses
Flaviviruses like dengue, West Nile, Zika, Japanese Encephalitis, and yellow fever infect over 400 million people a year ...
OCT 24, 2020
Immunology
New CRISPR-Based Imaging Tool Is Going to Be HiUGE
OCT 24, 2020
New CRISPR-Based Imaging Tool Is Going to Be HiUGE
A team of researchers at Duke University have developed an imaging technology for tagging structures at a cellular level ...
NOV 17, 2020
Immunology
6 Injections a Year Prevent HIV Infections
NOV 17, 2020
6 Injections a Year Prevent HIV Infections
Last year, around 1.7 million people became infected with HIV, with around half of these being women. Encouraging result ...
NOV 19, 2020
Immunology
Parasitic Worms Help Unravel the Immune Mechanisms Underlying Chronic Disease
NOV 19, 2020
Parasitic Worms Help Unravel the Immune Mechanisms Underlying Chronic Disease
Parasitic worms known as helminths have a complicated relationship with the immune systems of the hosts they invade. Ter ...
Loading Comments...